A nurse is assessing a client with suspected hyperparathyroidism. Which assessment finding would be most indicative of this condition?

Hyperparathyroidism is characterized by excessive secretion of parathyroid hormone (PTH), which primarily regulates calcium and phosphorus metabolism. The hallmark laboratory finding is hypercalcemia.

Hyperparathyroidism is a condition where one or more of the four parathyroid glands located behind the thyroid gland secrete too much parathyroid hormone (PTH). PTH plays a key role in maintaining calcium balance in the body through several mechanisms.

When PTH levels rise, it leads to increased calcium absorption in the intestines, increased calcium reabsorption in the kidneys, and increased calcium release from bones through osteoclast activation. This results in hypercalcemia, which is the most important and diagnostic lab finding in hyperparathyroidism.

A serum calcium level of 11.5 mg/dL in option 1 clearly exceeds the normal range of 8.5–10.5 mg/dL, making it the most characteristic finding. This hypercalcemia explains many of the patient's symptoms: bone pain (due to increased bone resorption), fatigue and weakness (due to effects on neuromuscular function), polyuria and polydipsia (due to calcium's impact on kidney function), and recurrent kidney stones (due to increased calcium excretion).

Pathophysiologically, it involves a breakdown of the normal feedback loop where rising calcium levels should decrease PTH secretion. However, in hyperparathyroidism, this regulatory mechanism fails, and PTH continues to be secreted despite high calcium levels. This triggers a systemic chain reaction that particularly affects the skeletal, renal, and gastrointestinal systems.

From a nursing perspective, recognizing hypercalcemia is crucial because it can lead to serious complications such as cardiac arrhythmias, kidney dysfunction, neurological changes, and severe bone disease. Early detection through testing allows for prompt intervention and prevents progression to more severe symptoms of the condition.

Understanding Primary Hyperparathyroidism
The scenario describes a client with fatigue, weakness, bone pain, polyuria, polydipsia, and a history of recurrent kidney stones. This clinical picture is classic for primary hyperparathyroidism (PHPT), a disorder of calcium and phosphate metabolism.

Analyzing the Laboratory Values
The hallmark of PHPT is the simultaneous elevation of parathyroid hormone (PTH) and serum calcium, with a corresponding decrease in serum phosphorus. This is because PTH acts on bone, kidneys, and the gastrointestinal tract to increase extracellular calcium concentration.

* Option 1: Serum calcium level of 11.5 mg/dL (normal: 8.5-10.5 mg/dL)
This is the most indicative finding. Hypercalcemia is the central biochemical abnormality in PHPT. A systematic review and meta-analysis on diagnostic tools for PHPT confirms that serum calcium-based indices are fundamental for diagnosis, with the condition being characterized by elevated serum calcium in the context of non-suppressed PTH ^[1]. The client’s symptoms of fatigue, weakness, bone pain, polyuria, and polydipsia are all direct clinical manifestations of sustained hypercalcemia.

* Option 2: Serum phosphorus level of 4.2 mg/dL (normal: 2.5-4.5 mg/dL)
This value is within the normal range. In PHPT, PTH increases renal excretion of phosphate, which typically leads to hypophosphatemia (a low serum phosphorus level). A normal or high-normal phosphorus level would be an atypical finding and does not support a primary diagnosis of PHPT.

* Option 3: Blood glucose level of 110 mg/dL (normal: 70-100 mg/dL)
While this is a mildly elevated fasting glucose, it is not a diagnostic indicator for hyperparathyroidism. It is not directly related to the PTH-calcium axis and would point toward an assessment for impaired glucose tolerance or diabetes, not PHPT.

* Option 4: Serum magnesium level of 1.8 mg/dL (normal: 1.5-2.5 mg/dL)
This is a normal value. While magnesium is involved in PTH secretion, a normal magnesium level does not rule in or rule out PHPT. The primary screening tests for suspected PHPT are serum calcium and PTH levels.

Clinical Correlation and Complication
The client's history of recurrent kidney stones is a significant complication of PHPT. Chronic hypercalcemia leads to increased calcium filtration by the kidneys, which can precipitate and form calcium-based stones. A study on renal calcifications in PHPT found a high prevalence of nephrolithiasis in these patients, highlighting that renal complications are a common and serious manifestation of the disease . Furthermore, the client's bone pain is explained by the catabolic effect of excess PTH on bone. Research confirms that PHPT negatively affects bone microarchitecture, as assessed by methods like the Trabecular Bone Score, demonstrating a direct link between the biochemical severity of the disease and structural bone damage . A separate study also reinforces that preoperative biochemical parameters, including calcium and PTH levels, correlate with the volume of the parathyroid adenoma, which is the most common cause of PHPT . The adenoma's size directly influences the severity of the biochemical derangements and, consequently, the clinical symptoms.